tiprankstipranks
Daré Bioscience Inc (DARE)
NASDAQ:DARE
US Market
DARE
Daré Bioscience
RESEARCH TOOLSreports
Want to see DARE full AI Analyst Report?

Daré Bioscience (DARE) Ratios

1,886 Followers

Daré Bioscience Ratios

DARE's free cash flow for Q4 2025 was $0.06. For the 2025 fiscal year, DARE's free cash flow was decreased by $ and operating cash flow was $-1.44. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Mar 25Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.14 1.14 0.85 0.86 1.36
Quick Ratio
 1.14 1.14 0.85 0.86 1.36
Cash Ratio
 1.04K 1.04K 0.73 0.51 1.10
Solvency Ratio
 -0.39 -0.38 -0.14 -1.14 -0.95
Operating Cash Flow Ratio
 -0.42 -417.38 0.25 -1.90 -0.57
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ -2.57M$ -2.57M$ -9.67M$ -8.79M$ 10.32M
Leverage Ratios
Debt-to-Assets Ratio
 81.79 81.79 0.06 0.07 0.01
Debt-to-Equity Ratio
 934.35 934.35 -0.22 -0.28 0.04
Debt-to-Capital Ratio
 1.00 1.00 -0.28 -0.39 0.04
Long-Term Debt-to-Capital Ratio
 0.65 0.65 0.00 0.00 0.00
Financial Leverage Ratio
 11.42 11.42 -3.68 -4.22 3.94
Debt Service Coverage Ratio
 -16.45 -13.86 0.00 0.00 0.00
Interest Coverage Ratio
 -19.68 -16.47 0.00 0.00 0.00
Debt to Market Cap
 0.27 0.02 0.00 0.00 0.00
Interest Debt Per Share
 183.23 23.77 0.15 0.19 0.07
Net Debt to EBITDA
 1.95K 1.93K 0.61 0.30 1.09
Profitability Margins
Gross Profit Margin
-276.15%-137.55%-146110.22%-670.62%-201.42%
EBIT Margin
-1284.20%-1315.51%-239692.20%-1094.77%-313.85%
EBITDA Margin
-1099.76%-1106.68%-239259.61%-1093.40%-313.61%
Operating Profit Margin
-1315.51%-1315.51%-239692.20%-1101.89%-313.85%
Pretax Profit Margin
-1300.66%-1300.66%-41430.90%-1074.17%-309.48%
Net Profit Margin
-1300.66%-1300.66%-41430.90%-1074.17%-309.48%
Continuous Operations Profit Margin
-1300.66%-1300.66%-41430.90%-1074.17%-309.48%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
98.87%98.87%17.29%97.48%98.61%
Return on Assets (ROA)
-41.26%-41.26%-18.34%-141.72%-70.61%
Return on Equity (ROE)
322.94%-471.37%67.42%597.53%-278.50%
Return on Capital Employed (ROCE)
-154.20%-154.20%-4765.42%-3858.90%-257.21%
Return on Invested Capital (ROIC)
-124.50%-124.50%-2253.31%-2435.24%-249.07%
Return on Tangible Assets
-41.26%-41.26%-18.34%-141.72%-70.61%
Earnings Yield
-41.63%-6.21%-15.29%-104.96%-44.09%
Efficiency Ratios
Receivables Turnover
 1.80 1.80 0.04 2.96 5.87
Payables Turnover
 3.23 2.04 9.83 6.39 14.86
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 <0.01 <0.01 <0.01 1.42 19.13
Asset Turnover
 0.03 0.03 <0.01 0.13 0.23
Working Capital Turnover Ratio
 0.29 9.49 >-0.01 0.66 0.39
Cash Conversion Cycle
 89.94 23.95 8.54K 66.28 37.61
Days of Sales Outstanding
 203.04 203.04 8.58K 123.39 62.17
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 113.09 179.08 37.15 57.11 24.56
Operating Cycle
 203.04 203.04 8.58K 123.39 62.17
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.68 -88.43 0.63 -5.34 -2.57
Free Cash Flow Per Share
 -0.71 -91.88 0.57 -5.43 -2.58
CapEx Per Share
 0.03 3.45 0.07 0.09 <0.01
Free Cash Flow to Operating Cash Flow
 1.04 1.04 0.89 1.02 1.00
Dividend Paid and CapEx Coverage Ratio
 -25.66 -25.66 9.41 -61.73 -286.80
Capital Expenditure Coverage Ratio
 -25.66 -25.66 9.41 -61.73 -286.80
Operating Cash Flow Coverage Ratio
 >-0.01 -3.72 4.14 -27.67 -37.01
Operating Cash Flow to Sales Ratio
 -9.60 -9.60K 551.33 -13.84 -1.81
Free Cash Flow Yield
-48.59%-4760.67%18.19%-137.41%-25.86%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -2.28 -16.10 -6.54 -0.95 -2.27
Price-to-Sales (P/S) Ratio
 19.50 209.43 2.71K 10.23 7.02
Price-to-Book (P/B) Ratio
 10.76 75.90 -4.41 -5.69 6.32
Price-to-Free Cash Flow (P/FCF) Ratio
 -1.96 -0.02 5.50 -0.73 -3.87
Price-to-Operating Cash Flow Ratio
 -3.09 -0.02 4.91 -0.74 -3.88
Price-to-Earnings Growth (PEG) Ratio
 <0.01 -0.11 0.07 0.17 0.05
Price-to-Fair Value
 10.76 75.90 -4.41 -5.69 6.32
Enterprise Value Multiple
 1.94K 1.92K -0.52 -0.64 -1.15
Enterprise Value
 -22.03B -21.84B 12.12M 19.66M 36.02M
EV to EBITDA
 1.94K 1.92K -0.52 -0.64 -1.15
EV to Sales
 -21.39K -21.20K 1.24K 7.00 3.60
EV to Free Cash Flow
 2.15K 2.13 2.51 -0.50 -1.98
EV to Operating Cash Flow
 2.23K 2.21 2.25 -0.51 -1.99
Tangible Book Value Per Share
 0.20 0.03 -0.71 -0.69 1.58
Shareholders’ Equity Per Share
 0.20 0.03 -0.71 -0.69 1.58
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.07 <0.01 <0.01 0.39 1.42
Net Income Per Share
 -0.92 -0.12 -0.48 -4.15 -4.39
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.01 0.99 0.17 0.98 0.99
Research & Development to Revenue
 4.37 5.36K 1.45K 7.67 3.00
SG&A to Revenue
 8.25 8.51 935.82 4.03 1.06
Stock-Based Compensation to Revenue
 0.71 1.45K 225.19 0.90 0.22
Income Quality
 0.74 0.74 -1.33 1.29 0.58
Currency in USD